EVERMIL 10 Tablets EVERMIL 10 contains Everolimus, an inhibitor of mammalian target of rapamycin (mTOR), a key serine-threonine kinase in the PI3K/AKT pathway. By binding to the intracellular protein FKBP-12, it forms a complex that directly inhibits mTOR complex 1 (mTORC1), blocking cell proliferation, protein synthesis, and angiogenesis. It is indicated for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer, advanced renal cell carcinoma (RCC), neuroendocrine tumors (NET) of gastrointestinal, lung, or pancreatic origin, and renal angiomyolipoma associated with tuberous sclerosis complex (TSC).